News | News By Subject | News by Disease News By Date | Search News

Chemotherapy/Radiation adjuvant News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FDA Clears INSYS' Syndros     7/5/2016
Bay Area's Heron (HRTX) Surges as the FDA Finds No Deficiency with SUSTOL NDA, Starts Labeling Discussions     4/19/2016
Heron (HRTX)'s Sustol Finally Gets a Date with the FDA     3/3/2016
FDA Needs More Time, Delays Assigning Action Date for Heron (HRTX)'s SUSTOL NDA     2/29/2016
Merrimack (MACK) Ramps Up Sales Force in Anticipation of Regulatory Approval of Pancreatic Cancer Drug     9/10/2015
Tesaro (TSRO) Wins FDA Nod for Chemotherapy-Induced Nausea Drug Varubi     9/2/2015
Bay Area's Heron (HRTX) Rockets as Nausea Drug Meets Goals in Phase III Study     6/1/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea     10/10/2014
Genentech (RHHBY)'s Avastin Approved for Wider Use in Colorectal Cancer     1/24/2013
FDA Approves QIAGEN N.V. (QGEN) KRAS Test for Use With Eli Lilly and Company (LLY) and Bristol-Myers Squibb Company (BMY)'s Cancer Drug Erbitux     7/9/2012
FDA Approves BTG plc (BGC.L)'s Drug for Cancer Toxicity     1/19/2012
ImClone Systems Incorporated (IMCL) and Bristol-Myers Squibb Company (BMY) Erbitux Extends Head, Neck Cancer Survival in Study Conducted by Merck KGaA (MKGAF.PK) in Germany     9/11/2008

News from Around the Web
Duke University Develops Nano-scale Drug Delivery for Chemotherapy     11/2/2009
Cancer Doctors Fear Chemo Drug Shortage     12/17/2008
National Cancer Institute Study Provides Clues about How Cancer Cells Develop Resistance to Chemotherapy Drug; Gene Boosts Resistance to Chemo Drug     9/15/2008
Antiangiogenic Drugs Impede Chemotherapy-stimulated Tumor Recovery, University of Toronto Study     9/10/2008
Targeted Radiation Therapy Can Control Limited Cancer Spread, University of Chicago Medical Center Study     8/13/2008
Novel Chemo Drug Helps Treat Prostate Cancer, Oregon Health & Science University (OHSU) Study Finds     6/3/2008
Chemo Fails To Root Out Breast Cancer Stem Cells, Baylor College of Medicine Study     4/30/2008
Chemotherapy Drug Cisplatin Fails To Improve Disease-free Survival; Results In More Colostomies, University of Texas M. D. Anderson Cancer Center Study     4/23/2008
Common Chemotherapy Drug Linked to Memory Problems, University of Rochester and Harvard Medical School Study     4/22/2008
New Chemotherapy Combo Produces Side Effects, But No Extra Efficacy, In Early Breast Cancer Patients     4/17/2008
Chemotherapy May Not Affect Memory In Breast Cancer Patients     4/16/2008
New Way To Fight Cancer: Protect Healthy Cells With The Silver Shield     4/2/2008
Postoperative Chemotherapy Does Not Improve Survival In Gastric Cancer Patients, Study Suggests     3/31/2008
Gemcitabine Not a Clear Winner for Adjuvant Treatment of Pancreatic Cancer, University of Maryland Study     3/5/2008
Missing Chromosome Predicts Brain Tumor Patients' Response To Treatment     2/19/2008

Press Releases
Saladax Biomedical Inc. (SBI) Release: Recent Study Shows Chemotherapy Toxic Effects Reduced Through Personalized Dosing     11/15/2016
RadioMedix Successfully Completed The Phase I/ II Clinical Studies For Aminomedix Used For Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT)     10/20/2016
Heron (HRTX) Announces FDA Approval Of SUSTOL (Granisetron) Extended-Release Injection For The Prevention Of Chemotherapy-Induced Nausea And Vomiting     8/10/2016
GenomeDx Biosciences's Decipher Platform Identifies Gene Expression Associated With Resistance To Chemotherapy Treatment In Bladder Cancer     5/9/2016
Biologics, Inc. (NC) To Be Exclusive Specialty Pharmacy Provider For Vistogard (Uridine Triacetate)     3/9/2016
Boehringer Ingelheim Release: European Committee For Medicinal Products For Human Use Recommends Approval Of Giotrif (Afatinib) For Advanced Squamous Cell Cancer Of The Lung     2/29/2016
Oncotelic Presents The Synergy Of OT-101 (A Late Stage TGF beta inhibitor) And A Chemotherapy Agent     2/9/2016
FDA Approves Merck & Co. (MRK)'s Single-Dose EMEND (Fosaprepitant Dimeglumine) For Injection, In Combination With Other Antiemetic Agents, For The Prevention Of Delayed Nausea And Vomiting In Adults Receiving Moderately Emetogenic Chemotherapy (MEC)     2/4/2016
NextSource Biotechnology Gains FDA Approval For New 5 Mg Strength Of Gleostine® (Lomustine), An Anti-Cancer Chemotherapy Agent     1/20/2016
GlycoMimetics, Inc. (GLYC) Presents Preclinical Data At American Society of Hematology Annual Meeting Showing GMI-1359 Enhances Efficacy Of Chemotherapy In FLT-3 AML Model     12/7/2015
Sensus Healthcare Receives FDA 510k Clearance For Next Generation Image Guided Superficial Radiotherapy SRT-100 Vision     10/19/2015
Tesaro (TSRO) Announces Inclusion Of VARUBI (Rolapitant) In NCCN Antiemesis Guidelines     9/24/2015
Pluristem Therapeutics (PSTI) and National Institute of Allergy And Infectious Diseases (NIAID) Complete FDA Meeting on PLX-R18 Cells in ARS     9/21/2015
Wellstat Therapeutics Corporation’ New Drug Application For Uridine Triacetate As Antidote To Overexposure To Chemotherapy Drug 5-Fluorouracil (5-FU) Accepted For Review By FDA     9/10/2015
NanoString (NSTG) Release: ESMO Clinical Practice Guidelines For Breast Cancer Recommend The Use Of Prosigna/PAM50 Assay For Determining Potential Benefit From Chemotherapy     9/9/2015

//-->